Association between polymorphisms of the renin-angiotensin system and coronary artery disease in Chinese patients with type 2 diabetes

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 13, Issue 2, 2012, Pages 305-313

  Lei, He Ping ^a   Chen, Hong Mei ^a   Zhong, Shi Long ^a   Yao, Qing Zhou ^a   Tan, Hong Hong ^a   Yang, Min ^a   Lin, Qiu Xiong ^a   Shan, Zhi Xin ^a   Zheng, Zhi Wei ^a   Zhu, Jie Ning ^a   Zhou, Zhi Ling ^a   Lin, Shu Guang ^a   Yu, Xi Yong ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Coronary artery disease; gene polymorphism; renin angiotensin system; risk factor; type 2 diabetes mellitus

Indexed keywords

ACE GENE; AGED; ALLELE; ARTICLE; AT 2R GENE; CHINESE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPING TECHNIQUES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, GENETIC; MULTIFACTOR DIMENSIONALITY REDUCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RENIN-ANGIOTENSIN SYSTEM;

EID: 84861859219     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320311435533     Document Type: Article

References (38)

1. Dzielńska Z, Małek LA, Roszczynko M, et al. Combined renin-angiotensin system gene polymorphisms and outcomes in coronary artery disease-a preliminary report. Kardiol Pol. 2011 ; 69: 688-695
2. Jiang X, Sheng H, Li J, et al. Association between renin-angiotensin system gene polymorphism and essential hypertension: a community-based study. J Hum Hypertens. 2009 ; 23: 176-181
3. Bouba I, Makrydimas G, Kalaitzidis R, et al. Interaction between the polymorphisms of the renin-angiotensin system in preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2003 ; 110: 8-11 (Pubitemid 37025689)
4. Markoula S, Giannopoulos S, Kostoulas C, et al. Gender association of the angiotensin-converting enzyme gene with ischaemic stroke. J Renin Angiotensin Aldosterone Syst. 2011 ; 12 (4). 510-515
5. Konopka A, Szperl M, Piotrowski W, et al. Influence of renin-angiotensin system gene polymorphisms on the risk of ST-segment-elevation myocardial infarction and association with coronary artery disease risk factors. Mol Diagn Ther. 2011 ; 15: 167-176
6. Hunyady L, Catt KJ. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol. 2006 ; 20: 953-970
7. Muller DN, Luft FC. The renin-angiotensin system in the vessel wall. Basic Res Cardiol. 1998 ; 93: 7-14 (Pubitemid 28498124)
8. Parving HH, de Zeeuw D, Cooper ME, et al. ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy. J Am Soc Nephrol. 2008 ; 19: 771-779
9. Tikellis C, Bernardi S, Burns WC. Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease. Curr Opin Nephrol Hypertens. 2011 ; 20: 62-68
10. Thomas MC, Pickering RJ, Tsorotes D, et al. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Circ Res. 2010 ; 107: 888-897
11. Zhong J, Yan Z, Liu D, et al. Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome. J Lab Clin Med. 2006 ; 147: 91-95 (Pubitemid 43189001)
12. Ribeiro-Oliveira A, Nogueira AI, Pereira RM, et al. The renin-angiotensin system and diabetes: an update. Vasc Health Risk Manag. 2008 ; 4: 787-803
13. Lanz JR, Pereira AC, Lemos PA, et al. Angiotensinogen M235T polymorphism is associated with coronary artery disease severity. Clin Chim Acta. 2005 ; 362: 176-181 (Pubitemid 41597103)
14. Jaffe IZ, Mendelsohn ME. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ Res. 2005 ; 96: 643-650 (Pubitemid 40478331)
15. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007 ; 292: C82 - C97
16. van Geel PP, Pinto YM, Voors AA, et al. Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension. 2000 ; 35: 717-721 (Pubitemid 30165315)
17. Sakuta T, Morita Y, Satoh M, et al. Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers. Arthritis Rheum. 2010 ; 62: 1319-1328
18. Carstens N, van der Merwe L, Revera M, et al. Genetic variation in angiotensin II type 2 receptor gene influences extent of left ventricular hypertrophy in hypertrophic cardiomyopathy independent of blood pressure. J Renin Angiotensin Aldosterone Syst. 2011 ; 12: 274-280
19. Herrmann SM, Nicaud V, Schmidt-Petersen K, et al. Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studies. Eur J Heart Fail. 2002 ; 4: 707-712 (Pubitemid 35403078)
20. Jones A, Dhamrait SS, Payne JR, et al. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension. 2003 ; 42: 500-506 (Pubitemid 37237345)
21. Swales JD, Dzau VJ. ACE inhibition: research advances and clinical implications. Am Heart J. 1992 ; 123: 1412-1414
22. Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997 ; 349: 747-752 (Pubitemid 27122456)
23. Alvarez R, Reguero JR, Batalla A, et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Cardiovasc Res. 1998 ; 40: 375-379 (Pubitemid 28506048)
24. Amir O, Amir R, Yamin C, et al. The ACE deletion allele is associated with Israeli elite endurance athletes. Exp Physiol. 2007 ; 92: 881-886 (Pubitemid 47283915)
25. Akbar SA, Khawaja NP, Brown PR, et al. Angiotensin II type 1 and 2 receptors gene polymorphisms in pre-eclampsia and normal pregnancy in three different populations. Acta Obstet Gynecol Scand. 2009 ; 88: 606-611
26. Buraczynska M, Ksiazek P, Drop A, et al. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol Dial Transplant. 2006 ; 21: 979-983
27. Andersson B, Blange I, Sylvén C. Angiotensin-II type 1 receptor gene polymorphism and long-term survival in patients with idiopathic congestive heart failure. Eur J Heart Fail. 1999 ; 1: 363-369 (Pubitemid 30131044)
28. Yi L, Gu YH, Wang XL, et al. Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from north-western China. J Int Med Res. 2006 ; 34: 272-283 (Pubitemid 44057270)
29. Lou XY, Chen GB, Yan L, et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet. 2007 ; 80: 1125-1137 (Pubitemid 47579348)
30. Jackson A, Brown K, Langdown J, et al. Effect of the angiotensin- converting enzyme gene deletion polymorphism on the risk of venous thromboembolism. Br J Haematol. 2000 ; 111: 562-564
31. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992 ; 359: 641-644
32. Ruiz J, Blanché H, Cohen N, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1994 ; 91: 3662-3665 (Pubitemid 24139491)
33. Samani NJ, Thompson JR, O'Toole L, et al. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation. 1996 ; 94: 708-712 (Pubitemid 26289226)
34. Fujimura T, Yokota M, Kato S, et al. Lack of association of angiotensin converting enzyme gene polymorphism or serum enzyme activity with coronary artery disease in Japanese subjects. Am J Hyperten. 1997 ; 10: 1384-1390 (Pubitemid 28078742)
35. Nakauchi Y, Suehiro T, Yamamoto M, et al. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor. gene polymorphisms as risk factors for coronary heart disease. Atherosclerosis. 1996 ; 125: 161-169 (Pubitemid 26249206)
36. Lin J, Hu FB, Qi L, et al. Genetic polymorphisms of angiotensin-2 type 1 receptor and angiotensinogen and risk of renal dysfunction and coronary heart disease in type 2 diabetes mellitus. BMC Nephrol. 2009 ; 10: 9
37. Abboud N, Ghazouani L, Kaabi B, et al. Evaluation of the contribution of renin angiotensin system polymorphisms to the risk of coronary artery disease among Tunisians. Genet Test Mol Biomarkers. 2010 ; 14: 661-666
38. Yan QN, Xu CS, Li ZL, et al. Relationship of angiotensin-converting enzyme 2 gene polymorphisms and vulnerability to coronary heart disease in patients with type 2 diabetes mellitus. Nan Fang Yi Ke Da Xue Xue Bao. 2008 ; 28: 1365-1368